Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

PerTrac annual study finds new single manager hedge fund launches up 51% in 2010, AuM up 11% from previous year to $1.6tn

Wednesday, April 20, 2011
Opalesque Industry Update - PerTrac, the leading provider of analytics, reporting and communications software for investment professionals, announced the release of its latest industry study, Sizing The 2010 Hedge Fund Universe: A PerTrac Study. The study indicates that the single-manager hedge fund industry recovered in 2010 with assets under management (AUM) increasing 11% over 2009 to $1.6 trillion and 1,184 new funds launching representing a 51% increase over the prior year. Total AUM for single-manager hedge funds and fund of funds was $2.1 trillion in 2010.

Fund of funds continue to see AUM decline. The 3,196 fund of funds in the study – approximately the same number as in 2008 – had $518 billion under management in 2010. This represents a 10.5% decrease from 2009 and a steep 31% decline from 2008 when $750 billion was reported.

Commodity Trading Advisors (CTAs), the third category measured in the study, attracted investors in 2009 as a haven from stocks and bonds as their numbers peaked that year at 2,425. In 2010, the number of CTAs dropped to 1,997 which is approximately the same level as in 2008.

“As we look across the fund universe, one clear area of growth has been in the number of single-manager hedge funds, and we see that momentum continuing in the future,” said Lisa Corvese, Managing Director, Global Business Strategy at PerTrac. “Overall, the study demonstrates a rebound -- with the industry as a whole getting closer to prior peaks.”

The PerTrac study of hedge funds is unique because it is the only study that aggregates information from 10 leading global databases, allowing it to obtain a holistic picture of the industry. With its proprietary analytics software that removes duplicative fund data, PerTrac provides the most precise and most comprehensive information about the number of funds and assets under management.

Other key findings in the PerTrac study, which has been conducted annually since 2003, show that:

• There are 9,572 single-manager hedge funds;

• Almost half (3,763) of the reporting single-manager funds have less than $25 million in AUM;

• Single-manager funds are growing in AUM with 73% reporting less than $100 million in AUM in 2010 compared to 79% in 2009;

• Most fund of funds are small with just 108 (3.3%) reporting AUM of greater than $1 billion and 70% reporting less than $100 million AUM and almost 42% reporting less than $25 million AUM.

• Approximately 47% of all funds report to only one database which means investors need to use more than one database to ensure they have complete information on single-manager funds.

To download the complete study which includes additional data on the composition and size of the hedge fund industry, please click here.

(press release)


PerTrac provides sophisticated analytics, reporting and communications software and services for investment professionals, including pensions, family offices, hedge funds, long-only managers, endowments, sovereign wealth funds, fund of funds and industry service providers. More than 1,400 organizations in 50 countries rely on PerTrac software solutions to help them maximize returns, reduce risk and operate more efficiently. Founded in 1996, PerTrac is headquartered in New York with offices in London, Hong Kong, Tokyo, Reno, and Memphis. For additional information on the full suite of PerTrac software solutions, please visit www.PerTrac.com.


See our recent article :
Opalesque Exclusive: 25% growth driven by pensions, endowments and foundations bolstering their in house hedge fund capabilities – PerTrac
Source

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for